Company / Gross Margin
Biogen Gross Margin History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
86.6%
FY2020
5-year range
-
FY2016-FY2020
Trend
+0.2%
vs FY2019
Sector context
#7 of 26
Health Care
What the data says
At 86.6%, Biogen's gross margin ranks #7 of 26 in the Health Care sector. Gross Margin returned to growth in FY2020 after 3 years of decline, reaching 86.6%.
Based on SEC 10-K filings.
86.6% in FY2020 with a 3-year CAGR of -0.1%. Top quartile in the Health Care sector.
Remained stable around 86.6% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -0.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#7 of 26 in Health CareTop 27% of 26This company 86.6% Sector average 61.9%
▼
+39.9% above sector average
Key checks
Key Insights
- In FY2020, gross margin increased 0.2% year-over-year.
- Currently 24.7pp above the Health Care sector average.
- Peak gross margin was recorded in FY2016.
- Lowest gross margin in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | 86.6% | +0.2% |
| FY2019 | 86.4% | -0.1% |
| FY2018 | 86.5% | -0.3% |
| FY2017 | 86.7% | -0.4% |
| FY2016 | 87.1% | -1.6% |
As of FY2020 · SEC 10-K · Updated Mar 3, 2026